STAT

Alarmed by new ‘CRISPR babies’ plan, top science figures say they’re powerless to stop it

Outraged by a new plan to create "CRISPR babies" in Russia, leading science figures concede that their organizations are powerless to stop it.
Dr. Margaret Hamburg serves as co-chair of an international advisory committee on human genome-editing.

ASPEN, Colo. — Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce gene-edited babies but conceded that it was beyond their organizations’ authority to halt him from doing so.

In separate interviews with STAT over the weekend, Margaret Hamburg, co-chair of an international advisory committee on human genome-editing, and Victor Dzau, president of the U.S. National Academy of Medicine, said they were deeply concerned by the plans outlined by Russian scientist Denis Rebrikov.

Still, said Hamburg, “I don’t know where we get the

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks